Has Katherine Manno, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,784 in general payments to Katherine Manno, MD across 260 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katherine Manno, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katherine Manno, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katherine Manno, MD

Dermatology · Reno, NVNPI 1225474224

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.2% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,762, more than ten times the $53 reported in 2020.

$5,784in general payments, 2019–2025

Across 260 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Sun Pharmaceutical Industries Inc.$749
Novartis$658
Johnson & Johnson$603
Lilly USA, LLC$512
Sanofi$378
plus $2K from 13 others

What the payments were for

Food & beverage$5,44894%
Education$3356%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	64	$1,326
Sun Pharmaceutical Industries Inc.	29	$749
Novartis	26	$658
Johnson & Johnson	33	$603
Lilly USA, LLC	16	$512
Sanofi	13	$378
LEO Pharma Inc.	17	$351
UCB, Inc.	11	$208
Arcutis Biotherapeutics, Inc.	10	$154
Pfizer	7	$151
Regeneron Healthcare Solutions, Inc.	5	$150
Amgen	6	$131
Dermavant Sciences, Inc.	7	$113
E.r. Squibb & Sons, L.L.C.	5	$109
Ortho Dermatologics, A Division Of Bausch Health US, LLC	6	$104
Organon	2	$27
Boehringer Ingelheim	1	$27
Hill Dermaceuticals, Inc.	1	$19
Genentech USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OLUMIANT$232

How this compares

$5,784 in reported general payments places this provider in the 60th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada →

Medicare billing

Part B allowed, 2024

$286,714

Medicare patients

784

Services billed

5,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	28	$102,959
Fluorouracil	57	$3,727
Acitretin	12	$3,152
Clobetasol Propionate	76	$3,027
Tretinoin	35	$2,223
Tacrolimus	18	$1,863
Hydroxychloroquine Sulfate	11	$1,515
Triamcinolone Acetonide	115	$1,029
Minoxidil	81	$1,011
Ketoconazole	53	$805
Doxycycline Hyclate	38	$772
Metronidazole	20	$681
Imiquimod	24	$621
ValacyclovirValacyclovir Hcl	41	$502
Clindamycin Phosphate	13	$388

Paid to pharmacies, not to this prescriber.

Other dermatology in Reno

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →